Duo Oncology Options Nanoparticle Platform from University of Pittsburgh

Written by Striking Alchemy

Duo Oncology signed an option to exclusively license nanoparticle prodrug chemistry patented developed in the laboratory of Dr. Song Li and patented by the University of Pittsburgh.

Read more about this milestone here

Striking Alchemy www.strikingalchemy.com
Previous

Duo Oncology Appoints Dr. Stanley Marks to Board of Directors